| 2025-10-25 |
BWLEX6959092332 |
PRASCO LLC |
15172.0 kg |
902230.0
|
TADALAFIL TABLETS,USP . MG,( CT) X BLISTE RS NDC NO.: - - ( X X = NO S)TADALAFIL TABLETS,USP MG NDC NO.: - - ( X = NOS) TADALAFIL TABLETS,USP MG NDC NO.: - - ( X = NOS) |
| 2025-09-16 |
NXGWHYDDDB39692 |
RISING PHARMA HOLDINGS INC |
4615.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR . ) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-09-15 |
MEDUKD031317 |
RISING PHARMA HOLDINGS INC |
14197.0 kg |
520821.0
|
LEVETIRACETAM TABLETS USP MG NDC NO: - - BATCH NUMBER: LE A, LE A, LE A LEVETIRACETAM TABLETS USP MG N DC NO: - - BATCH NUMBER: LE B, LE A, LE A LEVETIRACETAM TABLETS USP MG NDC NO: - - BATCH NUMBER: LE A, LE A, LE A, LE A, LE A INV NO: VKT/EX/ / - DT: - |
| 2025-09-14 |
YASVBOM0074591 |
GLENMARK PHARMACEUTICALS INC |
3025.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-08-23 |
BWLEX6958872962 |
PRASCO LLC |
5369.0 kg |
902230
|
X RF STC (TWENTY SEVEN) PACKAGES OF TADA LAFIL TABLETS,USP . MG ( CT) X BLISTERS - NDCNO: - - - X X = NO S T ADALAFIL TABLETS,USP MG - NDCNO: - - - X = NO SINV NO : VKT/EX/ / - DT : / / SB NO: DT : / / HS CODE : NET WT : . KGS |
| 2025-08-21 |
GISQIN250410 |
GRANULES USA A DIVISION OF GRANULES |
1761.0 kg |
961100
|
SAID TO CONTAIN, SHIPPER S LOAD STOW AND COUNT 10 PACKAGES FAMOTIDINE TABLETS, USP 10MG NDC NO. 71821-012-08 5841611 NO S BATCH NO S #FAM1025029A, FAM1025030A, FAM1025031A, FAM1025032A, FAM1025033A, FAM1025034A (MFG DATE : MAY 2025, EXP DATE : APRIL 2028) |
| 2025-08-01 |
YASVBOM0073594 |
GLENMARK PHARMACEUTICALS INC |
452.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-07-31 |
BWLEX6958827820 |
PRASCO LLC |
8153.0 kg |
300490
|
1X40RF STC 39 (THIRTY NINE )PACKAGES OFTADALAFIL TABLETS,USP 5MGNDC NO:35573-461-30(INV QTY 158904X30=4767120NOS)INV NO:VKT/EX/023/25-26DT :17/06/2025SB NO:2828325 DT: 19/06/2025HSCODE :30049099NET WT :4608.200 KGS |
| 2025-07-22 |
DMALHYDA12922 |
GRANULES USA INC |
6629.0 kg |
310510
|
FAMOTIDINE TABLETS, USP 10 MG |
| 2025-07-22 |
MAEU254789458 |
ASCEND LABORATORIES LLC |
9857.18 kg |
262060
|
1 X 40RF FCL TOTAL 42 PAC KAGES ONLY FAMOTIDINE TAB LETS, USP 20MG NDC NO.: 6787 7-842-10 FAMOTIDINE TABLETS, USP 40MG NDC NO.:67877-889- 01 FAMOTIDINE TABLETS, USP 4 0MG NDC NO.:67877-889-05 TOTAL NET WT.: 6841.100 ALSO NOTIFY: ASCEND LABORATOR IES, LLC |
| 2025-07-22 |
NXGWHYDDBC74963 |
RISING PHARMA HOLDINGS INC |
5515.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-07-17 |
YASVBOM0073169 |
GLENMARK PHARMACEUTICALS INC |
7308.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-07-08 |
MAEU254394776 |
ASCEND LABORATORIES LLC |
8435.6 kg |
291229
|
33 PALLETS (1X40REFER PART O F FCL) (TOTAL: THIRTY THREE PALLETS ONLY) PHARMACEUT ICAL PRODUCTS FAMOTIDINE TABL ETS USP 20MG (1000S) NDC NO: 67877-842-10 FAMOTIDINE TABLE TS USP 40MG (500S) NDC NO: 67 877-889-05 S/BILL NO : 2118 673 DATE : 24-MAY-25 TEMPE |
| 2025-07-08 |
MAEU254739341 |
ASCEND LABORATORIES LLC |
9232.12 kg |
293399
|
35 PALLETS (1X40REFER PART O F FCL) (TOTAL: THIRTY FIVE PALLETS ONLY) PHARMACEU TICAL PRODUCTS FAMOTIDINE TAB LETS USP 20MG (1000S) NDC NO: 67877-842-10 FAMOTIDINE TABL ETS USP 40MG (500S) NDC NO: 6 7877-889-05 S/BILL NO. 2379 847 DTD. 02.06.2025 TEMP ERA |
| 2025-07-08 |
MAEU254544553 |
RISING PHARMA HOLDINGS INC |
5034.05 kg |
300490
|
TOTAL 38 PACKAGES SUMATRIPT AN TABLET USP 25MG NDC NO: 64 980-660-91 BATCH NUMBER S # S U2525001A, SU2525002A SUMAT RIPTAN TABLET USP 25MG NDC NO : 64980-660-27 BATCH NUMBER S # SU2525001B SUMATRIPTAN T ABLET USP 50MG NDC NO: 64980- 661-91 BATCH NUMBER S |
| 2025-07-08 |
MAEU254204868 |
ASCEND LABORATORIES LLC |
10702.69 kg |
310510
|
1 X 40RF FCL TOTAL 36 PAL LETS ONLY PHARMACEUTICAL PRODUCTS FAMOTIDINE TABLETS, USP 20MG NDC NO .: 67877-84 2-10 FAMOTIDINE TABLETS, USP 40MG NDC NO .:67877-889-05 FAMOTIDINE TABLETS, USP 20MG NDC NO .: 67877-842-10 FA MOTIDINE TABLETS, USP 40MG N DC NO . |
| 2025-07-01 |
NXGWHYDDAJ86964 |
RISING PHARMA HOLDINGS INC |
4554.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-06-20 |
NXGWHYDCZW98973 |
RISING PHARMA HOLDINGS INC |
8928.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-06-14 |
CMDUAMC2385915 |
RISING PHARMA HOLDINGS INC |
18669.0 kg |
300490
|
CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS LEVETIRACETAM TABLETS USP 250MG NDC NO: 64980-604-12 BATCH NUMBER S LE2525001A, LE2525002A LEVETIRACETAM TABLETS USP 500MG NDC NO: 64980-605-12 BATCH NUMBER S LE025009A, LE5025010A LEVETIRACETAM TABLETS USP 750MG NDC NO: 64980-606-12 BATCH NUMBER S LE7525005A LEVETIRACETAM TABLETS USP 750MG NDC NO: 64980-606-50 BATCH NUMBER S LE7525007A LEVETIRACETAM TABLETS USP 1000MG NDC NO: 64980-607-06 BATCH NUMBER S LE1025011A, LE1025012A, LE1025013A, LE1025014A, LE1025015A INV NO: VKT/EX/002/25-26 DT: 28-04-2025 BUYER S ORDER NO: 4500016152 DT:15-11-2024 4500016292 DT:16-12-2024 4500016485 DT: 15-01-2025 HS CODE: 30049082 SB NO: 1374782 DT: 29-04-2025 NET WT: 12431.800 KGS FREIGHT PREPAID |
| 2025-06-13 |
DMALHYDA12837 |
GRANULES USA INC |
221.0 kg |
300490
|
12 HDPE CONTAINERS PACKED IN 03 PALLETS ??FAMOTIDINE TABLETS, USP 10 MG??NDC:71821-012-08??2861640 NO S ??BATCH NO. S:FAM1025009A,FAM1025010A,FAM1025011A, ??MFG DATE: APRIL-2025 EXP DATE :MARCH-2028??INVOICE NO: VKT/EX/001/25-26, DT: 24.04.2025??BUYERS ORDER NO. AND DATE??PO NO:3200006217-R2, DT:21.02.2025??SB NO: 1525624 DT:05-MAY-2025??HS CODE: 3004.90.9260??NET WT.148.8 KGS |
| 2025-06-12 |
BWLEMAA58669646 |
PRASCO LLC |
4318.0 kg |
300490
|
1X40RF STC 22(TWENTY TWO )PACKAGES OFTADALAFIL TABLETS,USP 10MG NDC NO:35573-462-30 (INV QTY 4008X 30 =1200240NOS)TADALAFIL TABLETS,USP20MG NDC NO:35573-463-30 (INV QTY 40992X 30 =1229760 NOS)INV NO : VKT/EX/003/25-26 DT : 29/03/2025SB NO: 1405234 DT : 30 |
| 2025-06-11 |
COSU6417417471 |
GLENMARK PHARMACEUTICALS INC USA |
1792.0 kg |
310510
|
FAMOTIDINE TABLETS |
| 2025-06-10 |
MAEU252231511 |
ASCEND LABORATORIES LLC |
6795.84 kg |
293399
|
26 PALLETS (1X40REFER PART O F FCL) (TOTAL: TWENTY SIX PALLETS ONLY) PHARMACEUTI CAL PRODUCTS FAMOTIDINE TABLE TS USP 20MG (1000S) NDC NO: 6 7877-842-10 FAMOTIDINE TABLET S USP 40MG (500S) NDC NO: 678 77-889-05 S/BILL NO. 1414 701 DTD. 30.04.2025 TEM PERATURE SETTING: +20 DEGREE FREIGHT COLLECT |
| 2025-05-16 |
BWLEMAA58587543 |
PRASCO LLC |
10129.0 kg |
300490
|
1X40RF STC 25 (TWENTY FIVE) PACKAGES OFTADALAFIL TABLETS,USP 5MG NDC NO:35573-461-30 (INV QTY 63000X 30 =1890000 NOS)TADALAFIL TABLETS,USP 10MG NDC NO:35573-462-30 (INV QTY 26136 X30 =784080NOS)INV NO : VKT/EX/075/24-25 DT : 31/03/2025SB NO:9624127 DT.02. |
| 2025-05-14 |
CMDUAMC2376119 |
RISING PHARMA HOLDINGS INC |
14587.0 kg |
300490
|
CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS LEVETIRACETAM TABLETS USP 500MG NDC NO:64980-605-12 BATCH NUMBER S LE5025004A, LE5025005A, LE5025LEVETIRACETAM TABLETS USP 500MG NDC NO:64980-605-50 |
| 2025-05-13 |
MAEU252452583 |
ASCEND LABORATORIES LLC |
3367.53 kg |
293399
|
13 PALLETS (1X40REFER PART OF FCL) (TOTAL: THIRTEEN PALLETS ONLY) PHARMACEUTIC AL PRODUCTS FAMOTIDINE TABLET S USP 20MG (1000S) NDC NO: 67 877-842-10 FAMOTIDINE TABLETS USP 40MG (100S) NDC NO: 6787 7-889-01 S/BILL NO. 9663309 DTD. 04.04.2025 TEMPERA TURE |
| 2025-05-13 |
MAEU251620242 |
ASCEND LABORATORIES LLC |
9997.8 kg |
210690
|
1 CONTAINER SAID TO CONTAIN 42 PACKAGES 42 PALLETS (1X40REF ER PART OF FCL) (TOTAL: FORTY TWO PALLETS ONLY) PHARMACEUT ICAL PRODUCTS FAMOTIDINE TABL ETS USP 20MG (1000S) NDC NO: 67877-842-10 FAMOTIDINE TABLE TS USP 40MG (100S) NDC NO: 67 877-889-01 FAMOTI |
| 2025-04-30 |
YASVBOM0071412 |
GLENMARK PHARMACEUTICALS INC |
3294.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-04-13 |
NXGWHYDCXW66546 |
RISING PHARMA HOLDINGS INC |
7502.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-04-08 |
MAEU250179972 |
ASCEND LABORATORIES LLC |
4964.2 kg |
310510
|
19 PALLETS (1X40REFER PART OF FCL) (TOTAL: NINETEEN PALLETS ONLY) PHARMACEUTIC AL PRODUCTS FAMOTIDINE TABLET S USP 20MG (1000S) NDC NO: 67 877-842-10 FAMOTIDINE TABLETS USP 40MG (100S) NDC NO: 6787 7-889-01 FAMOTIDINE TABLETS U SP 40MG (500S) NDC NO: 6787 |
| 2025-04-08 |
MAEU250837333 |
M/S GLENMARK THERAPEUTICS INC USA |
2624.08 kg |
300490
|
16 PACKAGES 2626 CARTONS PHA RMACEUTICALS AS UNDER FAMOT IDINE TABLETS, USP 10MG 200 S NDC NO.72657011220 FDAPRODUC T CODE:60 S A A 22 HTS CODE: 3004.90.92.55 ANDA NO. 215822 FAMOTIDINE TABLETS, USP 20 MG 85 S NDC NO.72657011388 F DAPRODUCT CODE:60 S A A |
| 2025-03-18 |
MAEU249411613 |
ASCEND LABORATORIES LLC |
5362.91 kg |
291229
|
23 PALLETS (1X40REFER PART OF FCL) (TOTAL: TWENTY THR EE PALLETS ONLY) PHARMACE UTICAL PRODUCTS FAMOTIDINE TA BLETS USP 20MG (500S) NDC NO: 67877-842-05 FAMOTIDINE TABL ETS USP 40MG (100S) NDC NO: 6 7877-889-01 FAMOTIDINE TABLET S USP 40MG (500S) NDC NO: |
| 2025-03-18 |
CMDUAMC2350462 |
RISING PHARMA HOLDINGS INC |
16279.0 kg |
300490
|
CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS LEVETIRACETAM TABLETS USP 750MG NDC NO:64980-606-12 BATCH NUMBER S LE7525001A, LE7525002A LEVETIRACETAM TABLETS USP 1000MG NDC NO:64980-607-06 BATCH |
| 2025-03-14 |
BWLEMAA58378493 |
PRASCO LLC |
3314.0 kg |
300490
|
1X20RF FCL STC 18 (EIGHTEEN ) PACKAGES OFTADALAFIL TABLETS,USP 5MG NDC NO:35573-461-30 (INV QTY 63936X 30 = 1918080 NOS)INV NO : VKT/EX/061/24-25DT : 27/01/2025SB NO :7678164 / DT.28.01.2025HS CODE : 30049099NET WT : 1854.100KGS |
| 2025-02-11 |
MAEU248673283 |
ASCEND LABORATORIES LLC |
3644.22 kg |
441520
|
33 PALLETS (1X40REFER PART OF FCL) (TOTAL: THIRTY THRE E PALLETS ONLY) PHARMACEU TICAL PRODUCTS FAMOTIDINE TAB LETS USP 40MG (100S) NDC NO: 67877-889-01 FAMOTIDINE TABLE TS USP 40MG (500S) NDC NO: 67 877-889-05 DATA LOGGER NO. TNLU670543, BATCH NO. FA402407 7A PALLET 01 OF 02 DATA LOGGE R NO. TNLU670505, BATCH NO. F4 024081A, PALLET 02 OF 02 S/BILL NO. 6958318 DTD. 02.01.2025 TEMPERATURE SE TTING: +20 DEGREE FREIGHT PREPAID |
| 2025-02-11 |
MAEU248370012 |
ASCEND LABORATORIES LLC |
1283.23 kg |
170240
|
4 PALLETS ( 87 PACKAGES) (1 X40REFER PART OF FCL) (TOT AL: FOUR PALLETS CONTAINING EIGHTY SEVEN SHIPPERS ON LY) PHARMACEUTICAL PRODUCTS AMLODIPINE BESYLATE TAB 5MG (1000S) NDC NO: 67877-198-10 S/BILL NO. 6974081 DTD. 02. 01.2025 TEMPERATURE SETTING : +20 DEGREE DATA LOGGER NO : TNLU650936 BATCH NO: AM0524 076A SHIPPER NO : 02 OF 04 FREIGHT PREPAID. |
| 2025-02-09 |
GISQIN241761 |
GRANULES USA INC |
3935.0 kg |
300490
|
SAID TO CONTAIN, SHIPPER S LOAD STOW AND COUNT 12 PACKAGES FAMOTIDINE TABLETS, USP 20MG NDC NO : 71821-010-12 30481086 NO S BATCH NUMBER S # FAM2024049A, FAM2024052A FAM2024053A (MFG DT : NOVEMBER-2024 EXP DT : OCTOBER-2027) BATCH NUMBER S # FAM2024054A, FAM2024055A FAM2024059A (MFG DT : DECEMBER-2024 EXP DT : NOV EMBER-2027) H.S CODE : 30049099 INVOICE : VKT/EX/057/24-25 DT : 30.12.2024 BUYER S ORDER NO. & DATE : 3200005951 DATE : 18.09.2024 SB NO : 6950487 DT : 01.01.2025 TEMP SET POINT: +18 DEGREES CELSIUS NET WEIGHT : 3170.0 KGS |
| 2025-02-09 |
NXGWHYDCVX91660 |
RISING PHARMA HOLDINGS INC |
7567.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2025-02-05 |
BWLEMAA48290367 |
PRASCO LLC |
1038.0 kg |
310510
|
TADALAFIL TABLETS |
| 2025-02-03 |
YASVBOM0068985 |
GLENMARK PHARMACEUTICALS INC |
7155.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-01-22 |
MAEU247904560 |
ASCEND LABORATORIES LLC |
2214.93 kg |
310510
|
10 PALLETS (1X40REFER PART OF FCL) (TOTAL: TEN PALLE TS ONLY) PHARMACEUTICAL PR ODUCTS FAMOTIDINE TABLETS USP 40MG (100S) NDC NO: 67877-88 9-01 FAMOTIDINE TABLETS USP 4 0MG (500S) NDC NO: 67877-889- 05 S/BILL NO. 6250782 DTD. 07.12.2024 TEMPER ATURE SETTING: +20 DEGREE FREIGHT COLLECT |
| 2025-01-18 |
BWLEMAA48191286 |
PRASCO LLC |
8299.0 kg |
300490
|
TADALAFIL TABLETS,USP 5 MG NDC NO:35573-461-30 (INV QTY 134304 X 30 = 4029120 NOS)TADALAFIL TABLETS,USP 10 MG NDC NO:35573-462-30 (INV QTY 13344 X 30 = 400320 NOS)TADALAFIL TABLETS,USP 10 MG NDC NO:35573-462-30 (INV QTY 13560X 30 = 406800 NOS)INV NO : VKT/EX/043/24-25D T : 22/11/2024INV NO :VKT/EX/041/24-25 DT :31 /10/2024SB.NO.5840322 / DT.23.11.2024SB.NO.5840541 / DT.23.11.2024HS CODE : 30049099NET WT: 4648.10 KGS |
| 2025-01-18 |
BWLEMAA48214323 |
PRASCO LLC |
3255.0 kg |
300490
|
4 PKGS OF LCL STC TADALAFIL TABLETS,USP 5 MG NDC NO:35573-461-30 (INV QTY 63432 X 30 = 1902960 NOS)INV NO : VKT/EX/046/24-25DT : 27/11/2024SB NO : 5977363 / DT.28.11.2024HS CODE : 30049099NET WT : 1839.500 KGS |
| 2025-01-16 |
YASVBOM0068024 |
GLENMARK PHARMACEUTICALS INC |
2865.0 kg |
310510
|
FAMOTIDINE TABLETS, USP 20MG |
| 2025-01-13 |
GISQIN241593 |
GRANULES USA INC |
2571.0 kg |
300490
|
SAID TO CONTAIN, SHIPPER S LOAD STOW AND COUNT 8 PACKAGES FAMOTIDINE TABLETS, USP 20MG NDCNO : 71821-010-12 20129380 NO S BATCH NUMBER S # FAM2024044A, FAM2024045A FAM2024046A, FAM2024047A (MFG DT : NOVEMBER-2024 EXP DT : OCTOBER-2027) H.S CODE : 30049099 INVOICE : VKT/EX/047/24-25 DT : 30.11.2024 BUYER S ORDER NO . & DATE : 3200005874 DATE : 08.08.2024 SB NO: 6105042 DT: 02.12.2024 TEMP SET POINT: +18 DEGREES CELSIUS NET WEIGHT : 2093.5 KGS |
| 2025-01-08 |
MEDUVW289874 |
RISING PHARMA HOLDINGS INC |
13695.0 kg |
300490
|
LEVETIRACETAM TABLETS USP 500MG BATCH NUMBER S # LE5024010A, LE1024011A LEVETIRACETAM TABLETS USP 1000MG BATCH NUMBER S # LE1024014A LE1024015A, LE1024016A, LE1024017A, LE1024018A,LE1024019A, LE1024021A INVOICE NO: VKT/EX/03 9/24-25 DT:31-10-2024 BUYERS ORDER NO:4500014852 DT:21-05-2024 HS CODE: 30049082 SB NO:585 9502 DT:23-11-2024 NET WT:11951.300 KGS NAC: RISING PHARMACEUTICALS THE TEMPERATURE TO BE SET AT PLUS 20 DEGREE CELSIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTION |
| 2025-01-06 |
BWLEMAA48162311 |
PRASCO LLC |
8496.0 kg |
300490
|
1X40RF STC 40 (FOURTY ) PACKAGES OFTADALAFIL TABLETS, USP 5MG NDC NO.:35573TADALAFIL TABLETS, USP 10MG NDC NO.:3557TADALAFIL TABLETS, USP 20MG NDC NO.:3557INV NO : VKT/EX/040/24-25DT : 31-10-2024SB NO: 5520047 DT : 11.11.202 4HS CODE : 30049099NET WT : 4855.9 (KGS)SCAC : BWLE |
| 2024-12-17 |
BWLEMAA48076847 |
PRASCO LLC |
6753.0 kg |
300490
|
1X40RF STC 32 (THIRTY TWO )PACKAGES OFTADALAFIL TABLETS,USP 5MG NDC NO:35573-461-30 (INV QTY 131937 X 30 = 3958110 NOS)INV NO : VKT/EX/033/24-25DT : 30/09/2024SB NO :4888818 / DT.17.10.2024HS CODE : 30049099NET WT : 3825.900 KGSTEMPERATURE TO BE SET AT +25 DEG CELCIUS |
| 2024-12-17 |
BWLEMAA48076849 |
PRASCO LLC |
8145.0 kg |
382590
|
1X40RF STC 38(THRITY EIGHT)PACKAGES OF |
| 2024-12-17 |
MEDUVW113108 |
RISING PHARMA HOLDINGS INC |
13044.0 kg |
300490
|
LEVETIRACETAM TABLETS USP 250MG NDC NO:64980 - 604-12 211 78 X 120 - 2541360 NO S BATCH N UMBER S # LE2524003A & LE2524004A (MFG DT:SEPTEMBER-2024 EXP DT:AUGUST-2027 LEVETIRACETAM TABLETS USP 500MG NDC NO:64980- 605-12 11832X120 =1419840 NO S BATCH N UMBER S # LE5024009A (MFG DT:SEPTEMBER-2024 EXP DT:AUGUST-2027 L EVETIRACETAM TABLETS USP 750MG NDC NO:64980- 606-12 39552X120=4746240 NO S BATCH N UMBER S# LE7524007A LE7524008A,LE7524009A,LE75 2401 0A&LE7524011A (MFG DT:SEPTEMBER-2024 EXP DT:AUGUST-2027 LEVETIRACETAM TABLETS USP 750MG NDC NO:64980- 606-50 1920X500 =960000 NO S BATCH N UMBER S # LE7524012A (MFG DT:SEPTEMBER-2024 EXP DT:AUGUST-2027 LEVETIRACETAM TABLETS U SP 1000MG NDC NO:64980- 607-06 12024X60 = 709920 NO S BATCH N UMBER S # LE1024010A (MFG DT:SEPTEMBER-2024 EXP DT:AUGUST-2027 INVOICE NO: VKT/EX/038/24-25 DT:31-10-2024 BUYERS ORDERNO:4500014852 & 4500015308 DT:21-05-2024 & 0 9-08-2024 HS CODE: 30049082 SB NO:5339523 DT:04-11-2024 NET WT:11453.100 KGS NAC: RISING PHARMACEUTICALS THE TEMPERATURE TO BE SET AT 20 DEGREE CELSIUS IN ACCORDANCE WITH SHIPPER S INSTRUCTION |